Astellas Pharma Inc. (TYO: 4503)
Japan
· Delayed Price · Currency is JPY 1,750.50
-15.50 (-0.88%)
Oct 11, 2024, 3:15 PM JST
Astellas Pharma Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '24 Oct 10, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Market Capitalization | 3,138,871 | 2,946,773 | 3,381,409 | 3,519,738 | 3,161,421 | 3,105,395 | Upgrade
|
| Market Cap Growth | -26.16% | -12.85% | -3.93% | 11.33% | 1.80% | -2.54% | Upgrade
|
| Enterprise Value | 3,828,600 | 3,534,468 | 2,972,491 | 3,152,309 | 2,836,186 | 2,830,946 | Upgrade
|
| Last Close Price | 1750.50 | 1608.13 | 1775.21 | 1744.93 | 1513.90 | 1449.62 | Upgrade
|
| PE Ratio | 146.35 | 169.81 | 32.82 | 26.02 | 23.33 | 13.93 | Upgrade
|
| PS Ratio | 1.84 | 1.84 | 2.23 | 2.72 | 2.53 | 2.39 | Upgrade
|
| PB Ratio | 1.87 | 1.85 | 2.24 | 2.41 | 2.28 | 2.41 | Upgrade
|
| P/FCF Ratio | 23.98 | 21.92 | 11.61 | 15.53 | 11.48 | 17.18 | Upgrade
|
| P/OCF Ratio | 16.49 | 17.09 | 10.32 | 13.67 | 10.30 | 13.99 | Upgrade
|
| EV/Sales Ratio | 2.25 | 2.20 | 1.96 | 2.43 | 2.27 | 2.18 | Upgrade
|
| EV/EBITDA Ratio | 13.77 | 12.51 | 8.81 | 10.58 | 8.76 | 8.48 | Upgrade
|
| EV/EBIT Ratio | 41.08 | 28.37 | 12.83 | 14.45 | 11.30 | 10.58 | Upgrade
|
| EV/FCF Ratio | 29.25 | 26.29 | 10.20 | 13.90 | 10.30 | 15.66 | Upgrade
|
| Debt / Equity Ratio | 0.59 | 0.63 | 0.14 | 0.15 | 0.20 | 0.32 | Upgrade
|
| Debt / EBITDA Ratio | 3.55 | 3.57 | 0.61 | 0.72 | 0.86 | 1.25 | Upgrade
|
| Debt / FCF Ratio | 7.58 | 7.50 | 0.70 | 0.94 | 1.01 | 2.30 | Upgrade
|
| Asset Turnover | 0.52 | 0.53 | 0.63 | 0.56 | 0.54 | 0.62 | Upgrade
|
| Inventory Turnover | 1.38 | 1.38 | 1.76 | 1.60 | 1.56 | 1.83 | Upgrade
|
| Quick Ratio | 0.66 | 0.69 | 1.13 | 1.05 | 1.15 | 0.86 | Upgrade
|
| Current Ratio | 0.90 | 0.93 | 1.45 | 1.34 | 1.47 | 1.09 | Upgrade
|
| Return on Equity (ROE) | 1.32% | 1.10% | 6.65% | 8.72% | 9.02% | 15.34% | Upgrade
|
| Return on Assets (ROA) | 1.82% | 2.58% | 6.05% | 5.92% | 6.83% | 7.93% | Upgrade
|
| Return on Capital (ROIC) | 2.58% | 3.61% | 8.55% | 8.17% | 9.31% | 11.27% | Upgrade
|
| Earnings Yield | 0.68% | 0.58% | 2.92% | 3.53% | 3.81% | 6.29% | Upgrade
|
| FCF Yield | 4.17% | 4.56% | 8.62% | 6.44% | 8.71% | 5.82% | Upgrade
|
| Dividend Yield | 4.19% | 4.35% | 3.38% | 2.87% | 2.77% | 2.76% | Upgrade
|
| Payout Ratio | 583.25% | 684.38% | 101.66% | 68.69% | 63.15% | 37.63% | Upgrade
|
| Buyback Yield / Dilution | 1.06% | 1.39% | 1.38% | 0.41% | 1.03% | 2.91% | Upgrade
|
| Total Shareholder Return | 5.25% | 5.74% | 4.76% | 3.27% | 3.81% | 5.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.